Current Research Networks and Large Projects
Effects of Germline Structural Variation on the Biology and Pathology of the Large Intestine (2021-2024)
CIRCPAC – A National Randomized Trial Investigating the Clinical Benefit of circulating tumor DNA Guided Recurrence Surveillance After Resection for Pancreatic Cancer (2020-)
UTILITY - Using liquid tumor biopsies & genetic testing to guide personalized treatment of advanced prostate cancer: From discovery to clinical care. (2020-)
TOMBOLA - Treatment of Metastatic Bladder cancer at the time of biochemical reLApse following radicial cystectomy (2020-)
DCCC ctDNA Research Center - Danish National Center for Circulating Tumor DNA Guided cancer Treatment (2020-)
DCCC Danish circulating tumor DNA network (DCCC ctDNA) (2019-)
NorDCaP - Nordic Implementation of Personalised Prostate Cancer Diagnostics (2019-)
PRIMA - Early and accurate detection of prostate cancer in general practice (2018-)
IMPROVE - Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (2018-2025)
IMPROVE-IT - Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (2018-2025)
IMPROVE-IT2 - Implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer – intervention trial 2 (2018-2025)
"Individualized monitoring of cancer by deep sequencing of circulating tumor DNA in patients with advanced bladder cancer "(2017-)
PROCARIS - A new strategy to prevent overdiagnosis and overtreatment of non-aggressive prostate cancer in the aging male population (2016-)
PAGER - Analyzis of personal genomic rearrangements for surveillance of patients with bladder cancer (2013-)
OPRA - Oncology Precision Medicine Project Aarhus (2017-)
NEXT - Danish study of personalised cancer therapy based on tumor genetics (2017-)
""Early detection of recurrence and more curative therapy for colon cancer patients" (2016-2020)
PanCancer Analysis of Whole Genomes (PCAWG) Project (2015-)
Long non-coding RNAs as biomarkers and novel drivers of human bladder cancer (2014-)
Research Groups at MOMA
Bladder Cancer Group (Lars Dyrskjøt)
Colon Cancer Group (Claus Lindbjerg)
Prostate Cancer Group (Karina Dalsgaard Sørensen)
Medical Research Group (Claus Gravholt)